Publications by authors named "Sedat Altug"

Claim this Profile
D
Drug Development.
Nadir Ulu, Daniël Henri Swart, Zafer Sezer, Mustafa Mümtaz Mazıcıoğlu, Ahmet İnal

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis.
Burhan Engin, Müge Güler Özden, Özge Sevil Karstarlı Bakay, Selda Pelin Kartal, İlkin Zindancı

Dermatol Ther (Heidelb)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial.
Zafer Sezer, Ahmet Inal, Salih L Cinar, Mustafa M Mazicioglu, Sedat Altug

Dermatol Ther (Heidelb)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial.
James Chih-Hsin Yang, Jin Hyoung Kang, Tony Mok, Myung-Ju Ahn, Vichien Srimuninnimit, Sedat Altug

Eur J Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer.
Dae Ho Lee, Jung Shin Lee, Sang-We Kim, José Rodrigues-Pereira, Baohui Han, Sedat Altug

Eur J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma.
Chien-Te Li, Magdalena Marek, Salih Z Guclu, Younseup Kim, Mohamed Meshref, Sedat Altug

J Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.
Luis G Paz-Ares, Sedat Altug, Alexandra Thareau Vaury, Jesús Corral Jaime, Francesca Russo

BMC Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer.
Da-Tong Chu, Sang-We Kim, Hon-Ki Hsu, Gürsel Cok, Jaromir Roubec, Sedat Altug

Lung Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-four-hour variation of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway demonstrated by the mouse visceral pain model.
Orhan Uludag, Bahar Tunctan, Sedat Altug, Hakan Zengil, Nurettin Abacioglu

Chronobiol Int· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer.
Da-Tong Chu, Sang-We Kim, Han-Pin Kuo, Rifat Ozacar, Frantisek Salajka, Sedat Altug

Lung Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological time-dependent difference in effect of peroxynitrite demonstrated by the mouse hot plate pain model.
Sedat Altug, Orhan Uludag, Bahar Tunctan, Iclal Cakici, Hakan Zengil

Chronobiol Int· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis.
Bahar Tunçtan, Sedat Altug, Orhan Uludag, Beray Demirkay, Nurettin Abacioglu

Pharmacol Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts.
A Tuncay Demiryürek, Gülüzar Yildiz, Sibel Eşiyok, Sedat Altuğ

Pharmacol Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis